Additional information – Renal Lifecycle Trial

"SGLT2 inhibitors should also be made available to those with highest risk of problem"

Additional Information

Please use the resources below to find additional information about the Renal Lifecycle study.

Downloadable information

Webinars

Dr. Jeroen van der Net (Albert Schweitzer zh, NL) presents the Renal Lifecycle trial on the Scienceday of the Dutch Kidney Foundation (04-10-2025, in Dutch)
Prof. Ron Gansevoort (UMCG, NL) explains for the Scienceday of the Dutch Kidneypatient Society what the trial is all about (presented on 8 Oct 2022, in Dutch)

Interviews

Interview with Heleen Nijmeijer – trial coordinator, article in Wisselwerking, magazine for kidneypatients (Oct 2022, in Dutch)

Powerpoint presentation

Publications

Will SGLT2 inhibitors be effective and safe in patients with severe CKD, dialysis or kidney transplantation (Clinical Journal of the American Society of Nephrology, Nov 2023)